Title | Type | SJR | H index | Total Docs. (2012) | Total Docs. (3years) | Total Refs. (2012) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2012) | %Female (2012) | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | Current Medicinal Chemistry | journal | 1.538 Q1 | 202 | 504 | 1001 | 59089 | 5168 | 970 | 4.57 | 117.24 | 39.58 | |
2 | Current Pharmaceutical Design | journal | 1.280 Q1 | 183 | 585 | 1163 | 65504 | 4819 | 1058 | 3.77 | 111.97 | 37.84 | |
3 | Current Topics in Medicinal Chemistry | journal | 1.409 Q1 | 133 | 233 | 510 | 22139 | 1975 | 440 | 3.77 | 95.02 | 36.31 | |
4 | Current Drug Targets | journal | 1.332 Q1 | 119 | 194 | 483 | 18772 | 1881 | 438 | 4.21 | 96.76 | 34.09 | |
5 | Current Cancer Drug Targets | journal | 1.789 Q1 | 103 | 89 | 255 | 9901 | 1288 | 238 | 4.31 | 111.25 | 36.86 | |
6 | Mini-Reviews in Medicinal Chemistry | journal | 0.941 Q1 | 107 | 140 | 364 | 12246 | 1255 | 356 | 3.41 | 87.47 | 35.18 | |
7 | Anti-Cancer Agents in Medicinal Chemistry | journal | 1.027 Q2 | 108 | 121 | 293 | 11637 | 971 | 261 | 3.00 | 96.17 | 40.32 | |
8 | CNS and Neurological Disorders - Drug Targets | journal | 1.492 Q1 | 96 | 123 | 237 | 9055 | 913 | 208 | 3.68 | 73.62 | 38.30 | |
9 | Current Vascular Pharmacology | journal | 0.975 Q2 | 69 | 107 | 217 | 8016 | 744 | 205 | 3.15 | 74.92 | 27.27 | |
10 | Current Gene Therapy | journal | 1.565 Q1 | 80 | 45 | 141 | 5121 | 693 | 127 | 5.30 | 113.80 | 43.02 | |
11 | Combinatorial Chemistry and High Throughput Screening | journal | 0.607 Q2 | 70 | 87 | 293 | 4972 | 632 | 261 | 1.99 | 57.15 | 28.79 | |
12 | Current Nanoscience | journal | 0.453 Q2 | 52 | 135 | 296 | 4918 | 504 | 292 | 1.52 | 36.43 | 34.61 | |
13 | Current Neuropharmacology | journal | 0.799 Q2 | 103 | 35 | 170 | 4661 | 494 | 162 | 2.30 | 133.17 | 30.39 | |
14 | Current Drug Delivery | journal | 0.804 Q1 | 72 | 64 | 183 | 3473 | 491 | 179 | 2.93 | 54.27 | 37.95 | |
15 | Letters in Drug Design and Discovery | journal | 0.284 Q2 | 37 | 129 | 344 | 3925 | 319 | 342 | 0.93 | 30.43 | 39.89 | |
16 | Medicinal Chemistry | journal | 0.402 Q3 | 50 | 139 | 199 | 4664 | 317 | 197 | 1.48 | 33.55 | 41.95 | |
17 | Current Molecular Pharmacology | journal | 1.560 Q1 | 49 | 39 | 59 | 3998 | 291 | 57 | 4.38 | 102.51 | 40.00 | |
18 | Current Drug Discovery Technologies | journal | 0.801 Q2 | 49 | 34 | 94 | 2615 | 288 | 87 | 2.45 | 76.91 | 28.42 | |
19 | Infectious Disorders - Drug Targets | journal | 0.593 Q2 | 61 | 47 | 145 | 3616 | 275 | 129 | 1.89 | 76.94 | 36.72 | |
20 | Recent Patents on Anti-Cancer Drug Discovery | journal | 1.082 Q1 | 52 | 24 | 80 | 3030 | 254 | 77 | 2.98 | 126.25 | 41.41 | |
21 | Current Reviews in Clinical and Experimental Pharmacology | journal | 49 | 34 | 98 | 2712 | 252 | 95 | 2.60 | 79.76 | 28.95 | ||
22 | Current Drug Safety | journal | 0.428 Q3 | 41 | 63 | 136 | 2743 | 228 | 124 | 1.49 | 43.54 | 35.16 | |
23 | Reviews on Recent Clinical Trials | journal | 0.683 Q2 | 35 | 42 | 79 | 2507 | 186 | 79 | 2.00 | 59.69 | 35.81 | |
24 | Recent Advances in Drug Delivery and Formulation | journal | 41 | 22 | 55 | 2367 | 179 | 54 | 2.50 | 107.59 | 27.27 | ||
25 | Recent Patents on CNS Drug Discovery | journal | 0.803 Q2 | 36 | 25 | 58 | 3322 | 179 | 58 | 3.03 | 132.88 | 38.10 | |
26 | Cardiovascular and Hematological Agents in Medicinal Chemistry | journal | 0.502 Q3 | 43 | 34 | 78 | 3271 | 168 | 78 | 1.96 | 96.21 | 32.65 | |
27 | Recent Advances in Anti-Infective Drug Discovery | journal | 38 | 27 | 65 | 2250 | 163 | 64 | 2.82 | 83.33 | 34.04 | ||
28 | Current Pharmaceutical Analysis | journal | 0.425 Q2 | 27 | 48 | 96 | 1591 | 147 | 95 | 1.50 | 33.15 | 43.26 | |
29 | Recent advances in inflammation & allergy drug discovery | journal | 37 | 22 | 79 | 2504 | 141 | 79 | 1.46 | 113.82 | 35.85 | ||
30 | Current Pharmacogenomics and Personalized Medicine | journal | 0.368 Q3 | 20 | 41 | 89 | 2194 | 140 | 72 | 1.24 | 53.51 | 44.66 | |
31 | Drug Metabolism Letters | journal | 0.374 Q2 | 31 | 29 | 112 | 1010 | 140 | 111 | 1.39 | 34.83 | 44.35 | |
32 | Current Computer-Aided Drug Design | journal | 0.510 Q2 | 32 | 29 | 76 | 1626 | 134 | 70 | 1.80 | 56.07 | 26.76 | |
33 | Current Bioactive Compounds | journal | 0.660 Q1 | 31 | 46 | 80 | 2983 | 121 | 71 | 0.83 | 64.85 | 49.69 | |
34 | Cardiovascular and Hematological Disorders - Drug Targets | journal | 0.412 Q3 | 45 | 23 | 83 | 1226 | 111 | 77 | 1.38 | 53.30 | 37.50 | |
35 | Current Radiopharmaceuticals | journal | 0.392 Q3 | 32 | 45 | 95 | 2173 | 99 | 86 | 1.23 | 48.29 | 33.11 | |
36 | Open Medicinal Chemistry Journal | journal | 1.174 Q1 | 23 | 4 | 20 | 140 | 81 | 18 | 4.26 | 35.00 | 40.00 | |
37 | Anti-Inflammatory and Anti-Allergy Agents in Medicinal Chemistry | journal | 0.183 Q3 | 27 | 35 | 109 | 2441 | 66 | 98 | 0.47 | 69.74 | 51.65 | |
38 | Anti-Infective Agents | journal | 0.399 Q3 | 26 | 27 | 43 | 1255 | 59 | 40 | 1.22 | 46.48 | 34.00 | |
39 | Recent Patents on Endocrine, Metabolic and Immune Drug Discovery | journal | 0.179 Q4 | 28 | 25 | 75 | 2498 | 56 | 74 | 0.94 | 99.92 | 38.71 | |
40 | Current Enzyme Inhibition | journal | 0.221 Q3 | 19 | 12 | 68 | 1077 | 49 | 65 | 0.65 | 89.75 | 39.29 | |
41 | Current Drug Therapy | journal | 0.187 Q3 | 20 | 36 | 97 | 2407 | 47 | 91 | 0.36 | 66.86 | 29.47 | |
42 | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry | journal | 0.235 Q3 | 17 | 34 | 78 | 2748 | 37 | 70 | 0.39 | 80.82 | 28.45 | |
43 | Open Drug Discovery Journal | journal | 0.199 Q4 | 10 | 0 | 26 | 0 | 18 | 23 | 0.69 | 0.00 | 0.00 | |
44 | Frontiers in Drug Design and Discovery | book series | 0.125 Q4 | 9 | 0 | 18 | 0 | 3 | 17 | 0.00 | 0.00 | 0.00 | |
45 | Current Clinical Pharmacology | journal | 0.600 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
46 | Recent Patents on Drug Delivery and Formulation | journal | 0.783 Q1 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 | |
47 | Recent Patents on Inflammation and Allergy Drug Discovery | journal | 0.434 Q3 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | 0.00 |
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®